Processa Pharmaceuticals
Stock Forecast, Prediction & Price Target

Processa Pharmaceuticals Financial Estimates

Processa Pharmaceuticals Revenue Estimates

Processa Pharmaceuticals EBITDA Estimates

Processa Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $14.90M
Low: $14.90M
High: $14.90M
avg. 0%
Avg: $20M
Low: $20M
High: $20M
avg. 34.14%
Avg: $10.35M
Low: $10.35M
High: $10.35M
avg. -48.22%
Net Income
 
% change YoY
$-11.42M
 
N/A
$-54.84M
 
-379.96%
$-11.12M
 
79.72%
Avg: $-13.74M
Low: $-78.69M
High: $-27.67M
avg. -23.56%
Avg: $-14.60M
Low: $-81.31M
High: $-81.31M
avg. -6.30%
Avg: $-70.82M
Low: $-70.82M
High: $-70.82M
avg. -384.83%
EBITDA
 
% change YoY
$-10.76M
 
N/A
$-12.20M
 
-13.34%
$-11.45M
 
6.09%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.75
 
N/A
-$3.4
 
-353.33%
-$8.48
 
-149.41%
Avg: -$4.06
Low: -$6
High: -$2.11
avg. 52.18%
Avg: -$6.2
Low: -$6.2
High: -$6.2
avg. -52.89%
Avg: -$5.4
Low: -$5.4
High: -$5.4
avg. 12.90%
Operating Expenses
 
% change YoY
$11.56M
 
N/A
$20.25M
 
75.13%
$11.45M
 
-43.44%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Processa Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -138.23% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -78.69M, average is -13.74M and high is -27.67M.

What is Processa Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of -4.69% in 2025-2027.

We have gathered data from 2 analysts. Their low revenue estimate is $14.90M, average is $14.90M and high is $14.90M.

What is Processa Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 4.06% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$6, average is -$4.06 and high is $-2.11.